首页 > 最新文献

Journal of Research in Pharmacy Practice最新文献

英文 中文
Effectiveness of Plasmapheresis in Aluminum Phosphate Poisoning. 血浆置换治疗磷酸铝中毒的疗效。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-05-13 eCollection Date: 2021-01-01 DOI: 10.4103/jrpp.JRPP_21_27
Shiva Samsam Shariat, Shafeajafar Zoofaghari, Farzad Gheshlaghi
1. Tawfik HM. Recent advances in management of aluminium phosphide poisoning. QJM Int J Med 2020;113 Suppl 1:hcaa049.002. [doi: https://doi.org/10.1093/ qjmed/hcaa049.002]. 2. Elgazzar FM. Assessment of Intravenous lipid emulsion as an adjuvant therapy in acute aluminum phosphide poisoning: A randomized controlled trial. QJM Int J Med 2020;113 Suppl 1:hcaa049.001. [doi: https://doi.org/100.1093/ qjmed/hcaa049.001]. 3. Gheshlaghi F, Lavasanijou MR, Moghaddam NA, Khazaei M, Behjati M, Farajzadegan Z, et al. N-acetylcysteine, ascorbic acid, and methylene blue for the treatment of aluminium phosphide poisoning: Still beneficial? Toxicol Int 2015;22:40‐4. 4. Dorooshi G, Zoofaghari S, Mood NE, Gheshlaghi F. A newly proposed management protocol for acute aluminum phosphide poisoning. J Res Pharm Pract 2018;7:168-9. 5. Moghadamnia AA. An update on toxicology of aluminum phosphide. Daru 2012;20:25. 6. Tahergorabi Z, Zardast M, Naghizadeh A, Mansouri B, Nakhaei I, Zangouei M. Effect of aluminium phosphide (ALP) gas inhalation exposure on adipose tissue characteristics and histological toxicity in male rats. J Taibah Univ Sci. 2020;14:1317-25. Letter to the Editor
{"title":"Effectiveness of Plasmapheresis in Aluminum Phosphate Poisoning.","authors":"Shiva Samsam Shariat, Shafeajafar Zoofaghari, Farzad Gheshlaghi","doi":"10.4103/jrpp.JRPP_21_27","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_27","url":null,"abstract":"1. Tawfik HM. Recent advances in management of aluminium phosphide poisoning. QJM Int J Med 2020;113 Suppl 1:hcaa049.002. [doi: https://doi.org/10.1093/ qjmed/hcaa049.002]. 2. Elgazzar FM. Assessment of Intravenous lipid emulsion as an adjuvant therapy in acute aluminum phosphide poisoning: A randomized controlled trial. QJM Int J Med 2020;113 Suppl 1:hcaa049.001. [doi: https://doi.org/100.1093/ qjmed/hcaa049.001]. 3. Gheshlaghi F, Lavasanijou MR, Moghaddam NA, Khazaei M, Behjati M, Farajzadegan Z, et al. N-acetylcysteine, ascorbic acid, and methylene blue for the treatment of aluminium phosphide poisoning: Still beneficial? Toxicol Int 2015;22:40‐4. 4. Dorooshi G, Zoofaghari S, Mood NE, Gheshlaghi F. A newly proposed management protocol for acute aluminum phosphide poisoning. J Res Pharm Pract 2018;7:168-9. 5. Moghadamnia AA. An update on toxicology of aluminum phosphide. Daru 2012;20:25. 6. Tahergorabi Z, Zardast M, Naghizadeh A, Mansouri B, Nakhaei I, Zangouei M. Effect of aluminium phosphide (ALP) gas inhalation exposure on adipose tissue characteristics and histological toxicity in male rats. J Taibah Univ Sci. 2020;14:1317-25. Letter to the Editor","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"57"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f8/42/JRPP-10-57.PMC8259597.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39215056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of COVID-19 Treatment. COVID-19治疗综述。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-01-11 eCollection Date: 2020-10-01 DOI: 10.4103/jrpp.JRPP_20_72
Somayeh Sadeghi, Mahnaz Momenzadeh, Peiman Nasri, Mina Nickpour

Many contagious diseases, such as plague or cholera, played a role in changing the pathway of history. In this respect, although coronavirus was not as dangerous as novel diseases such as swine flu and Ebola, the spread and the power of coronavirus infiltration caused public fear across the world. Three viruses among coronaviruses have been epidemic during the recent years, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and COVID-19 or new coronavirus. Respiratory droplets transmit the coronavirus through direct and indirect contact, and it can be transmitted through the contact in the case of remaining, the infected person's secretion on the surface. Based on the conducted studies on the treatment of COVID-19 disease, there is virtually no cure or vaccine for coronavirus infections yet. Those infected with Covid 19 are quarantined to prevent the outbreak of this disease. However, the researchers carried out different studies to investigate the impact of the various drugs on this virus, which in this study, we will examine the outline of this disease and the other conducted studies.

许多传染病,如鼠疫或霍乱,在改变历史进程方面发挥了作用。在这方面,虽然冠状病毒不像猪流感和埃博拉等新型疾病那样危险,但冠状病毒的传播和渗透能力引起了全世界公众的恐惧。近年来,冠状病毒中有三种病毒流行,分别是严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS)和COVID-19或新型冠状病毒。呼吸道飞沫通过直接和间接接触传播冠状病毒,在表面残留感染者分泌物的情况下,可通过接触传播。根据对COVID-19疾病治疗的研究,目前还没有治愈新冠病毒感染的方法或疫苗。感染了Covid - 19的人被隔离,以防止这种疾病的爆发。然而,研究人员进行了不同的研究来调查各种药物对这种病毒的影响,在这项研究中,我们将研究这种疾病的概况和其他进行的研究。
{"title":"Review of COVID-19 Treatment.","authors":"Somayeh Sadeghi,&nbsp;Mahnaz Momenzadeh,&nbsp;Peiman Nasri,&nbsp;Mina Nickpour","doi":"10.4103/jrpp.JRPP_20_72","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_72","url":null,"abstract":"<p><p>Many contagious diseases, such as plague or cholera, played a role in changing the pathway of history. In this respect, although coronavirus was not as dangerous as novel diseases such as swine flu and Ebola, the spread and the power of coronavirus infiltration caused public fear across the world. Three viruses among coronaviruses have been epidemic during the recent years, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and COVID-19 or new coronavirus. Respiratory droplets transmit the coronavirus through direct and indirect contact, and it can be transmitted through the contact in the case of remaining, the infected person's secretion on the surface. Based on the conducted studies on the treatment of COVID-19 disease, there is virtually no cure or vaccine for coronavirus infections yet. Those infected with Covid 19 are quarantined to prevent the outbreak of this disease. However, the researchers carried out different studies to investigate the impact of the various drugs on this virus, which in this study, we will examine the outline of this disease and the other conducted studies.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"169-174"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f3/cb/JRPP-9-169.PMC8067900.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38919309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Assessment of Medication Adherence in Patients with Chronic Diseases in Tabuk, Kingdom of Saudi Arabia. 沙特阿拉伯王国Tabuk慢性疾病患者药物依从性评估
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-01-11 eCollection Date: 2020-10-01 DOI: 10.4103/jrpp.JRPP_20_97
Kousalya Prabahar, Maymonah Abdullah Albalawi, Lama Almani, Sarah Alenizy

Objective: Uncontrolled chronic diseases such as hypertension and diabetes mellitus can lead to severe complications. Poor adherence to medication is one of the important reasons, leading to complications for chronically diseased patients. We aimed to assess the trend toward medication adherence and the reasons for medication nonadherence in chronic disease patients in Tabuk city in Saudi Arabia.

Methods: A cross-sectional study was conducted at a tertiary care hospital in Tabuk, Saudi Arabia. Participants were selected and interviewed for information regarding their medication adherence. A medication adherence rating scale questionnaire was used to measure the level of adherence in study participants. The data were analyzed by the statistical package for the social sciences (SPSS) database 24.

Findings: Overall, 208 participants were involved in this study. Among these, 134 (64.4%) were female, and 74 (35.6%) were male. This study showed that 159 (76.44%) participants were adherent to their medications and nearly one-quarter of patients were nonadherent to their medications. No statistically significant differences were found between male and female patients toward their medication adherence. The primary intentional and nonintentional reason for nonadherence was side effects and forgetfulness, respectively.

Conclusion: Tailoring the therapy according to the individual need of the patients will maximize the patient's adherence toward medications.

目的:高血压、糖尿病等慢性疾病不加控制可导致严重并发症。服药依从性差是导致慢性病患者出现并发症的重要原因之一。我们旨在评估沙特阿拉伯Tabuk市慢性疾病患者药物依从性的趋势和药物不依从性的原因。方法:在沙特阿拉伯Tabuk的一家三级保健医院进行了一项横断面研究。参与者被选中并接受采访,以了解他们的药物依从性。使用药物依从性评定量表问卷来测量研究参与者的依从性水平。数据采用社会科学统计软件包(SPSS)数据库24进行分析。研究结果:总共有208名参与者参与了这项研究。其中女性134例(64.4%),男性74例(35.6%)。本研究显示,159名(76.44%)参与者坚持服药,近四分之一的患者不坚持服药。男性和女性患者在药物依从性方面没有统计学上的显著差异。不坚持治疗的主要故意和非故意原因分别是副作用和健忘。结论:根据患者的个性化需求定制治疗方案,可以最大限度地提高患者对药物的依从性。
{"title":"Assessment of Medication Adherence in Patients with Chronic Diseases in Tabuk, Kingdom of Saudi Arabia.","authors":"Kousalya Prabahar,&nbsp;Maymonah Abdullah Albalawi,&nbsp;Lama Almani,&nbsp;Sarah Alenizy","doi":"10.4103/jrpp.JRPP_20_97","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_97","url":null,"abstract":"<p><strong>Objective: </strong>Uncontrolled chronic diseases such as hypertension and diabetes mellitus can lead to severe complications. Poor adherence to medication is one of the important reasons, leading to complications for chronically diseased patients. We aimed to assess the trend toward medication adherence and the reasons for medication nonadherence in chronic disease patients in Tabuk city in Saudi Arabia.</p><p><strong>Methods: </strong>A cross-sectional study was conducted at a tertiary care hospital in Tabuk, Saudi Arabia. Participants were selected and interviewed for information regarding their medication adherence. A medication adherence rating scale questionnaire was used to measure the level of adherence in study participants. The data were analyzed by the statistical package for the social sciences (SPSS) database 24.</p><p><strong>Findings: </strong>Overall, 208 participants were involved in this study. Among these, 134 (64.4%) were female, and 74 (35.6%) were male. This study showed that 159 (76.44%) participants were adherent to their medications and nearly one-quarter of patients were nonadherent to their medications. No statistically significant differences were found between male and female patients toward their medication adherence. The primary intentional and nonintentional reason for nonadherence was side effects and forgetfulness, respectively.</p><p><strong>Conclusion: </strong>Tailoring the therapy according to the individual need of the patients will maximize the patient's adherence toward medications.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"196-201"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ed/20/JRPP-9-196.PMC8067897.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38919312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
The COVID-19 Vaccine Saga: A Perspective. COVID-19 疫苗传奇:透视。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-01-11 eCollection Date: 2020-10-01 DOI: 10.4103/jrpp.JRPP_20_100
Shashank M Patil, Ramith Ramu
{"title":"The COVID-19 Vaccine Saga: A Perspective.","authors":"Shashank M Patil, Ramith Ramu","doi":"10.4103/jrpp.JRPP_20_100","DOIUrl":"10.4103/jrpp.JRPP_20_100","url":null,"abstract":"","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"218-219"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b8/0a/JRPP-9-218.PMC8067902.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38839400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Common Opioids Involved in Drug Poisoning Presenting to the Emergency Department: A Cross-sectional Study. 急诊科常见阿片类药物中毒:一项横断面研究
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-01-11 eCollection Date: 2020-10-01 DOI: 10.4103/jrpp.JRPP_20_105
Nastaran Eizadi-Mood, Elham Haghshenas, Ali Mohammad Sabzghabaee, Ahmad Yaraghi, Ziba Farajzadegan

Objective: Opioids poisoning is of the most important cause of mortality. The objective of the study was to compare the demographic factors, clinical manifestations, and outcomes of the most common opioids involved in drug overdose presenting to the Emergency Department.

Methods: This cross-sectional study was conducted from October 2016 to March 2017 in the Clinical Toxicology Department of the main referral center of the university. All poisoning cases with common opioids were included in the study. Demographic factors, clinical manifestations, and outcome were recorded in a check list. ANOVA, Chi-square or Fisher's exact test, and binary logistic regression analysis were used for outcome prediction.

Findings: Two hundred and thirty six patients with opioids poisoning were evaluated during the study period. The most common opioids involved in poisoning were methadone (47.9%), tramadol (24.2%), and opium (21.6%). Patients with opium poisoning were older than others (P < 0.0001). The rate of suicide was more in the tramadol group, while the past history of psychological problems was more observed in the methadone group (P < 0.0001). Increasing age (odds ratio [OR], 1.05; 95% confidence interval [CI]: 1.02-1.09; P = 0.05) and addiction (P = 0.01; OR, 7; 95% CI: 1.55-31.52) was associated with an increased complications or death. Also patients with somatic disease had more chance of complications/death (P = 0.04; OR, 3.71; 95% CI: 1.06-12.97). Kind of opioids was not a predictive factor in the outcome of the patients with acute poisoning.

Conclusion: Age, addiction, and somatic disease should be considered as more important factors in outcome prediction with opioids poisoning, including opium, tramadol, and methadone.

目的:阿片类药物中毒是导致死亡的最主要原因。该研究的目的是比较急诊科最常见的阿片类药物过量的人口学因素、临床表现和结果。方法:本横断面研究于2016年10月至2017年3月在该大学主要转诊中心临床毒理学部进行。所有常见阿片类药物中毒病例均纳入研究。人口统计学因素、临床表现和结果记录在核对表中。结果预测采用方差分析、卡方检验或Fisher精确检验、二元logistic回归分析。结果:在研究期间对236例阿片类药物中毒患者进行了评估。最常见的阿片类药物中毒是美沙酮(47.9%)、曲马多(24.2%)和鸦片(21.6%)。鸦片中毒患者年龄大于其他患者(P < 0.0001)。曲马多组自杀率高于美沙酮组,美沙酮组有较多的心理病史(P < 0.0001)。年龄增加(优势比[OR], 1.05;95%置信区间[CI]: 1.02-1.09;P = 0.05)和成瘾性(P = 0.01;或者,7;95% CI: 1.55-31.52)与并发症增加或死亡相关。躯体疾病患者并发症/死亡的几率更高(P = 0.04;或者,3.71;95% ci: 1.06-12.97)。阿片类药物种类不是急性中毒患者预后的预测因素。结论:年龄、成瘾和躯体疾病是预测阿片类药物中毒(包括鸦片、曲马多和美沙酮)预后的更重要因素。
{"title":"Common Opioids Involved in Drug Poisoning Presenting to the Emergency Department: A Cross-sectional Study.","authors":"Nastaran Eizadi-Mood,&nbsp;Elham Haghshenas,&nbsp;Ali Mohammad Sabzghabaee,&nbsp;Ahmad Yaraghi,&nbsp;Ziba Farajzadegan","doi":"10.4103/jrpp.JRPP_20_105","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_105","url":null,"abstract":"<p><strong>Objective: </strong>Opioids poisoning is of the most important cause of mortality. The objective of the study was to compare the demographic factors, clinical manifestations, and outcomes of the most common opioids involved in drug overdose presenting to the Emergency Department.</p><p><strong>Methods: </strong>This cross-sectional study was conducted from October 2016 to March 2017 in the Clinical Toxicology Department of the main referral center of the university. All poisoning cases with common opioids were included in the study. Demographic factors, clinical manifestations, and outcome were recorded in a check list. ANOVA, Chi-square or Fisher's exact test, and binary logistic regression analysis were used for outcome prediction.</p><p><strong>Findings: </strong>Two hundred and thirty six patients with opioids poisoning were evaluated during the study period. The most common opioids involved in poisoning were methadone (47.9%), tramadol (24.2%), and opium (21.6%). Patients with opium poisoning were older than others (<i>P</i> < 0.0001). The rate of suicide was more in the tramadol group, while the past history of psychological problems was more observed in the methadone group (<i>P</i> < 0.0001). Increasing age (odds ratio [OR], 1.05; 95% confidence interval [CI]: 1.02-1.09; <i>P</i> = 0.05) and addiction (<i>P</i> = 0.01; OR, 7; 95% CI: 1.55-31.52) was associated with an increased complications or death. Also patients with somatic disease had more chance of complications/death (<i>P</i> = 0.04; OR, 3.71; 95% CI: 1.06-12.97). Kind of opioids was not a predictive factor in the outcome of the patients with acute poisoning.</p><p><strong>Conclusion: </strong>Age, addiction, and somatic disease should be considered as more important factors in outcome prediction with opioids poisoning, including opium, tramadol, and methadone.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"202-207"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c8/63/JRPP-9-202.PMC8067901.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38839403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological and Nonpharmacological Studies on Coronavirus Disease 2019: A Mini-review of the Recent Evidence. 2019 年冠状病毒疾病的药理和非药理研究:最新证据小综述》。
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-01-11 eCollection Date: 2020-10-01 DOI: 10.4103/jrpp.JRPP_20_71
Amir Hossein Alizadeh Bahmani, Mehdi Hoorang, Sheida Hosseini, Mehrnoosh Eskandari, Kiana Shayestehfard, Mahyar Shekoohi, Nazafarin Hatami-Mazinani, Saba Afifi, Ali Mohammad Sabzghabaee, Payam Peymani

Coronavirus 19 (COVID-19) is an extremely transmittable microbial infection that has emerged in Wuhan (China) in late 2019, leading to severe acute respiratory syndrome coronavirus 2 syndrome, and caused a pandemic all over the globe. This study is a systematic review of all 927 clinical trial studies performed worldwide from the beginning of the COVID-19 mysterious pandemic in China. These researches have registered in different databases. According to the best of our knowledge, China (74.82%), the United States (4.49%), and France (2.72%) have the most significant number of clinical trials, respectively. Clinical trials can be randomized or nonrandomized. Due to our results, 32.58% of studies were randomized, and 7.12% were not randomized. Most of the studies were open-labeled studies (22.44%), and double-blinded (4.42%) and quadruple blinded (2.48%) studies stand in second and third place regarding the number of trials, respectively. The direction and quantity of clinical trials attempted to identify a possible cure for COVID-19 demonstrates the depth of this crisis. As we are writing this article, a significant international endeavor will find a cure or vaccine for containing this devastating and mysterious disease.

冠状病毒19(COVID-19)是一种极易传播的微生物感染,2019年底在中国武汉出现,导致严重急性呼吸道综合征冠状病毒2综合征,并在全球引起大流行。本研究系统回顾了自中国 COVID-19 神秘大流行开始以来全球进行的所有 927 项临床试验研究。这些研究已在不同的数据库中登记。据我们所知,中国(74.82%)、美国(4.49%)和法国(2.72%)分别拥有最多的临床试验。临床试验可以是随机的,也可以是非随机的。根据我们的研究结果,32.58%的研究为随机研究,7.12%的研究为非随机研究。大部分研究为开放标签研究(22.44%),双盲研究(4.42%)和四重盲研究(2.48%)的数量分别排在第二和第三位。为寻找治疗 COVID-19 的可能方法而进行的临床试验的方向和数量表明了这场危机的严重性。就在我们撰写这篇文章的时候,国际上正在努力寻找治疗这种毁灭性神秘疾病的方法或疫苗。
{"title":"Pharmacological and Nonpharmacological Studies on Coronavirus Disease 2019: A Mini-review of the Recent Evidence.","authors":"Amir Hossein Alizadeh Bahmani, Mehdi Hoorang, Sheida Hosseini, Mehrnoosh Eskandari, Kiana Shayestehfard, Mahyar Shekoohi, Nazafarin Hatami-Mazinani, Saba Afifi, Ali Mohammad Sabzghabaee, Payam Peymani","doi":"10.4103/jrpp.JRPP_20_71","DOIUrl":"10.4103/jrpp.JRPP_20_71","url":null,"abstract":"<p><p>Coronavirus 19 (COVID-19) is an extremely transmittable microbial infection that has emerged in Wuhan (China) in late 2019, leading to severe acute respiratory syndrome coronavirus 2 syndrome, and caused a pandemic all over the globe. This study is a systematic review of all 927 clinical trial studies performed worldwide from the beginning of the COVID-19 mysterious pandemic in China. These researches have registered in different databases. According to the best of our knowledge, China (74.82%), the United States (4.49%), and France (2.72%) have the most significant number of clinical trials, respectively. Clinical trials can be randomized or nonrandomized. Due to our results, 32.58% of studies were randomized, and 7.12% were not randomized. Most of the studies were open-labeled studies (22.44%), and double-blinded (4.42%) and quadruple blinded (2.48%) studies stand in second and third place regarding the number of trials, respectively. The direction and quantity of clinical trials attempted to identify a possible cure for COVID-19 demonstrates the depth of this crisis. As we are writing this article, a significant international endeavor will find a cure or vaccine for containing this devastating and mysterious disease.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"175-180"},"PeriodicalIF":0.8,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/ca/JRPP-9-175.PMC8067895.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38919310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sensitivity and Specificity of prior Methicillin-Resistant Staphylococcus aureus Nasal Swab Results for Predicting Methicillin-Resistant Staphylococcus aureus Infections in Intensive Care Unit Admissions Over a 1-Year Period: A Pilot Study. 既往耐甲氧西林金黄色葡萄球菌鼻拭子结果预测1年重症监护病房住院患者耐甲氧西林金黄色葡萄球菌感染的敏感性和特异性:一项试点研究
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-01-11 eCollection Date: 2020-10-01 DOI: 10.4103/jrpp.JRPP_20_86
Jonathan Wadle, Geoffrey C Wall, Hayden S Smith

Objective: Methicillin-resistant Staphylococcus aureus (MRSA) continues to be a pathogen worldwide. Empiric anti-MRSA therapy is often prescribed in hospital inpatients with potential infection. Recent studies have suggested, particularly for respiratory infections, that MRSA colonization as determined by nasal swab has a high negative predictive value (NPV) for MRSA infections during the index hospitalization. We examined the predictive value of a prior intensive care unit (ICU) MRSA nasal swab on the results from a subsequent ICU admission in the same patient and the results of the latter admission MRSA nasal swab.

Methods: A retrospective chart review of patients 18 years or older admitted to a large tertiary care hospital in the Midwest of the United States in 2016 who had a MRSA nasal swab performed and had an ICU admission stay of over 24 h was conducted. This group of patients was matched to a patient list of subjects who were admitted as an inpatient to the same ICU at least once during the following year. Data were collected on demographic and clinical information, as well as the results of MRSA swabs and the presence of a MRSA infection during both hospitalizations. Predictive values were calculated using 2 × 2 tables including sensitivity and specificity of a first MRSA swab result with a MRSA infection during the subsequent ICU stay.

Findings: Seventy-seven patients were matched who had MRSA swabs performed on two separate ICU admissions. The negative predictive value of the first MRSA swab result on a MRSA infection during the second ICU stay was 96%.

Conclusion: In this pilot study, a previous negative MRSA nasal swab may predict a lack of a MRSA infection in a subsequent infection during a 1-year period.

目的:耐甲氧西林金黄色葡萄球菌(MRSA)仍然是世界范围内的一种病原体。经验性抗mrsa治疗通常用于潜在感染的住院患者。最近的研究表明,特别是呼吸道感染,通过鼻拭子确定的MRSA定植对住院期间MRSA感染具有很高的阴性预测值(NPV)。我们研究了重症监护室(ICU)前一次MRSA鼻拭子对同一患者随后ICU入院结果和后一次入院MRSA鼻拭子结果的预测价值。方法:回顾性分析2016年美国中西部某大型三级医院收治的18岁及以上、行MRSA鼻拭子检查且ICU住院时间超过24 h的患者。这组患者与一组患者名单相匹配,这些患者在接下来的一年中作为住院患者至少入住同一ICU一次。收集了人口统计学和临床信息,以及MRSA拭子结果和两次住院期间是否存在MRSA感染的数据。使用2 × 2表计算预测值,包括首次MRSA拭子结果与随后ICU住院期间MRSA感染的敏感性和特异性。结果:77例患者在两次单独的ICU住院期间接受了MRSA拭子检查。第一次MRSA拭子结果对第二次ICU住院期间MRSA感染的阴性预测值为96%。结论:在这项初步研究中,先前的MRSA阴性鼻拭子可以预测1年内后续感染中没有MRSA感染。
{"title":"Sensitivity and Specificity of prior Methicillin-Resistant <i>Staphylococcus aureus</i> Nasal Swab Results for Predicting Methicillin-Resistant <i>Staphylococcus aureus</i> Infections in Intensive Care Unit Admissions Over a 1-Year Period: A Pilot Study.","authors":"Jonathan Wadle,&nbsp;Geoffrey C Wall,&nbsp;Hayden S Smith","doi":"10.4103/jrpp.JRPP_20_86","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_86","url":null,"abstract":"<p><strong>Objective: </strong>Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) continues to be a pathogen worldwide. Empiric anti-MRSA therapy is often prescribed in hospital inpatients with potential infection. Recent studies have suggested, particularly for respiratory infections, that MRSA colonization as determined by nasal swab has a high negative predictive value (NPV) for MRSA infections during the index hospitalization. We examined the predictive value of a prior intensive care unit (ICU) MRSA nasal swab on the results from a subsequent ICU admission in the same patient and the results of the latter admission MRSA nasal swab.</p><p><strong>Methods: </strong>A retrospective chart review of patients 18 years or older admitted to a large tertiary care hospital in the Midwest of the United States in 2016 who had a MRSA nasal swab performed and had an ICU admission stay of over 24 h was conducted. This group of patients was matched to a patient list of subjects who were admitted as an inpatient to the same ICU at least once during the following year. Data were collected on demographic and clinical information, as well as the results of MRSA swabs and the presence of a MRSA infection during both hospitalizations. Predictive values were calculated using 2 × 2 tables including sensitivity and specificity of a first MRSA swab result with a MRSA infection during the subsequent ICU stay.</p><p><strong>Findings: </strong>Seventy-seven patients were matched who had MRSA swabs performed on two separate ICU admissions. The negative predictive value of the first MRSA swab result on a MRSA infection during the second ICU stay was 96%.</p><p><strong>Conclusion: </strong>In this pilot study, a previous negative MRSA nasal swab may predict a lack of a MRSA infection in a subsequent infection during a 1-year period.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"208-211"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/68/57/JRPP-9-208.PMC8067898.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38919315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Pharmacist Intervention on Medication Adherence and Clinical Outcomes of Type 2 Diabetes Mellitus Outpatients in Primary Healthcare in Indonesia. 药师干预对印尼初级卫生保健门诊2型糖尿病患者服药依从性和临床结局的影响
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-01-11 eCollection Date: 2020-10-01 DOI: 10.4103/jrpp.JRPP_20_59
Nani Apriani Besemah, Ratu Ayu Dewi Sartika, Rani Sauriasari

Objective: In Indonesia, the role of pharmacists in primary healthcare is still very limited or even absent. This study evaluates the effectiveness of programs delivered for type 2 diabetes mellitus (T2DM) patients by pharmacists in primary healthcare through counseling, short message service (SMS) reminders, and medication booklets.

Methods: A quasi-experimental study with a pretest-posttest design was conducted from April to August 2018 at Merdeka and Dempo primary health-care centers, Palembang, South Sumatra Province, Indonesia. Counseling and medication booklets were distributed three times during the study period, while SMS reminders were sent once a week. Counseling was given for the management of diabetes mellitus (DM), including during the Ramadan fasting period, together with management for acute and chronic complications. The medication adherence level was measured using a medication adherence questionnaire (MAQ) and pill count adherence (PCA). The study sample comprised 80 T2DM patients, who were allocated into either the control group (CG) (n = 40) or intervention group (IG) (n = 40). Clinical outcomes were determined by measuring glycated hemoglobin (HbA1c), blood pressure, and lipid profiles.

Findings: After the intervention, the IG showed significant improvements in most parameters, except for high-density lipoprotein cholesterol and systolic and diastolic blood pressure. HbA1c levels were reduced, while MAQ scores and PCA scores were improved. Lipid parameters were significantly reduced total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), and triglyceride (TG). Compared with the CG, most parameters were significantly improved in the IG. Pharmacist counseling significantly improved almost all clinical parameters (HbA1c, TC, LDL-c, and TG). Pharmacist counseling was 7.1 times greater in lowering HbA1c compared with no counseling, after adjusted by other variables. The variable that most influenced the lowering of HbA1c was infrequent ("not often") consumption of unhealthy foods (OR 14.9; 95% CI 3.5-63.7).

Conclusion: The pharmacist primary health-care intervention program implemented in this study significantly improved HbA1c, TC, LDL-c, TG, and medication adherence in outpatients with T2DM.

目的:在印度尼西亚,药剂师在初级卫生保健中的作用仍然非常有限,甚至不存在。本研究评估了药师在初级卫生保健中通过咨询、短信提醒和药物手册为2型糖尿病(T2DM)患者提供的方案的有效性。方法:2018年4 - 8月在印度尼西亚南苏门答腊省巨港市默迪卡和登波初级卫生保健中心采用前测后测设计进行准实验研究。研究期间发放了三次咨询和用药手册,并每周发送一次短信提醒。为管理糖尿病(DM)提供咨询,包括在斋月禁食期间,以及急性和慢性并发症的管理。采用药物依从性问卷(MAQ)和药丸数依从性(PCA)测量药物依从性水平。研究样本包括80例T2DM患者,分为对照组(CG) (n = 40)和干预组(IG) (n = 40)。通过测量糖化血红蛋白(HbA1c)、血压和血脂来确定临床结果。结果:干预后,IG除高密度脂蛋白胆固醇、收缩压和舒张压外,大多数参数均有显著改善。HbA1c水平降低,MAQ评分和PCA评分提高。脂质参数显著降低总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-c)和甘油三酯(TG)。与CG相比,IG组大部分参数均有明显改善。药师咨询可显著改善几乎所有临床参数(HbA1c、TC、LDL-c、TG)。经其他变量调整后,药师咨询降低HbA1c的效果是无药师咨询的7.1倍。对HbA1c降低影响最大的变量是不经常(“不经常”)食用不健康食品(OR 14.9;95% ci 3.5-63.7)。结论:本研究实施的药师初级卫生保健干预方案显著改善了门诊T2DM患者的HbA1c、TC、LDL-c、TG和药物依从性。
{"title":"Effect of Pharmacist Intervention on Medication Adherence and Clinical Outcomes of Type 2 Diabetes Mellitus Outpatients in Primary Healthcare in Indonesia.","authors":"Nani Apriani Besemah, Ratu Ayu Dewi Sartika, Rani Sauriasari","doi":"10.4103/jrpp.JRPP_20_59","DOIUrl":"10.4103/jrpp.JRPP_20_59","url":null,"abstract":"<p><strong>Objective: </strong>In Indonesia, the role of pharmacists in primary healthcare is still very limited or even absent. This study evaluates the effectiveness of programs delivered for type 2 diabetes mellitus (T2DM) patients by pharmacists in primary healthcare through counseling, short message service (SMS) reminders, and medication booklets.</p><p><strong>Methods: </strong>A quasi-experimental study with a pretest-posttest design was conducted from April to August 2018 at Merdeka and Dempo primary health-care centers, Palembang, South Sumatra Province, Indonesia. Counseling and medication booklets were distributed three times during the study period, while SMS reminders were sent once a week. Counseling was given for the management of diabetes mellitus (DM), including during the Ramadan fasting period, together with management for acute and chronic complications. The medication adherence level was measured using a medication adherence questionnaire (MAQ) and pill count adherence (PCA). The study sample comprised 80 T2DM patients, who were allocated into either the control group (CG) (<i>n</i> = 40) or intervention group (IG) (<i>n</i> = 40). Clinical outcomes were determined by measuring glycated hemoglobin (HbA1c), blood pressure, and lipid profiles.</p><p><strong>Findings: </strong>After the intervention, the IG showed significant improvements in most parameters, except for high-density lipoprotein cholesterol and systolic and diastolic blood pressure. HbA1c levels were reduced, while MAQ scores and PCA scores were improved. Lipid parameters were significantly reduced total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), and triglyceride (TG). Compared with the CG, most parameters were significantly improved in the IG. Pharmacist counseling significantly improved almost all clinical parameters (HbA1c, TC, LDL-c, and TG). Pharmacist counseling was 7.1 times greater in lowering HbA1c compared with no counseling, after adjusted by other variables. The variable that most influenced the lowering of HbA1c was infrequent (\"not often\") consumption of unhealthy foods (OR 14.9; 95% CI 3.5-63.7).</p><p><strong>Conclusion: </strong>The pharmacist primary health-care intervention program implemented in this study significantly improved HbA1c, TC, LDL-c, TG, and medication adherence in outpatients with T2DM.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"186-195"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/e6/JRPP-9-186.PMC8067894.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38919316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Evaluation of the Prescribed Drugs to Elderly in a Tertiary Healthcare Center for Possible Drug Interactions with Investigational Drugs for COVID-19 Treatment. 某三级医疗保健中心老年人处方药物与新冠肺炎治疗研究药物可能相互作用的评价
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-01-11 eCollection Date: 2020-10-01 DOI: 10.4103/jrpp.JRPP_20_107
Yogendra Keche, Nitin Gaikwad, Suryaprakash Dhaneria, Apoorva Joshi

Objective: Earlier identifying drug interactions may help in risk reduction in elderly patients.

Methods: Drug prescription data of 212 elderly patients of tertiary health care center had been analyzed for possible drug interactions with investigational drugs for COVID-19 treatment. Drug interaction had been checked from Stockley's Drug Interaction 2019 and Martindale the Complete Drug Reference 2017 and standard reference books of Pharmacology.

Findings: Different types of drugs prescribed in the elderly were 260 and out of which 68 (26.36%) were in the category of fixed-dose combinations. Around 150 (70.75%) elderly patients were having one or more associated comorbidities. Thirty-five drugs prescribed to elderly had been found to cause drug interaction with investigational drugs for COVID-19. Possible drug interactions are mediated through CYP3A4 (eighteen patients), CYP2D6 (seven patients) isoenzymes, or P glycoproteins transporters (three patients).

Conclusion: Possible drug interactions predicted in this study suggested need for modification of dose of drug or watchfulness for adverse effects. If these drug interactions are considered beforehand, complications can be prevented on account of these drug interactions in elderly who are suffering from COVID-19.

目的:早期识别药物相互作用可能有助于降低老年患者的风险。方法:分析三级卫生保健中心212例老年患者的药物处方资料,分析其与治疗新冠肺炎的研究药物可能存在的药物相互作用。药物相互作用已从Stockley的《药物相互作用2019》和Martindale的《药物完全参考2017》和药理学标准参考书中进行了检查。结果:老年人处方不同类型药物260种,其中固定剂量联合用药68种,占26.36%;约150例(70.75%)老年患者有一种或多种相关合并症。已发现35种老年人处方药物与新冠肺炎研究药物相互作用。可能的药物相互作用是通过CYP3A4(18例)、CYP2D6(7例)同工酶或P糖蛋白转运蛋白(3例)介导的。结论:本研究预测可能的药物相互作用提示需要调整药物剂量或注意不良反应。如果事先考虑到这些药物相互作用,则可预防感染COVID-19的老年人因这些药物相互作用而出现并发症。
{"title":"Evaluation of the Prescribed Drugs to Elderly in a Tertiary Healthcare Center for Possible Drug Interactions with Investigational Drugs for COVID-19 Treatment.","authors":"Yogendra Keche,&nbsp;Nitin Gaikwad,&nbsp;Suryaprakash Dhaneria,&nbsp;Apoorva Joshi","doi":"10.4103/jrpp.JRPP_20_107","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_107","url":null,"abstract":"<p><strong>Objective: </strong>Earlier identifying drug interactions may help in risk reduction in elderly patients.</p><p><strong>Methods: </strong>Drug prescription data of 212 elderly patients of tertiary health care center had been analyzed for possible drug interactions with investigational drugs for COVID-19 treatment. Drug interaction had been checked from Stockley's Drug Interaction 2019 and Martindale the Complete Drug Reference 2017 and standard reference books of Pharmacology.</p><p><strong>Findings: </strong>Different types of drugs prescribed in the elderly were 260 and out of which 68 (26.36%) were in the category of fixed-dose combinations. Around 150 (70.75%) elderly patients were having one or more associated comorbidities. Thirty-five drugs prescribed to elderly had been found to cause drug interaction with investigational drugs for COVID-19. Possible drug interactions are mediated through CYP3A4 (eighteen patients), CYP2D6 (seven patients) isoenzymes, or <i>P</i> glycoproteins transporters (three patients).</p><p><strong>Conclusion: </strong>Possible drug interactions predicted in this study suggested need for modification of dose of drug or watchfulness for adverse effects. If these drug interactions are considered beforehand, complications can be prevented on account of these drug interactions in elderly who are suffering from COVID-19.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"212-217"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ea/23/JRPP-9-212.PMC8067896.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38839399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicines Availability among Hypertensive Patients in Primary Health Care Facilities in a Rural Province in South Africa: Findings and Implications. 南非一个农村省初级卫生保健机构中高血压患者的药物可得性:研究结果和意义
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-01-11 eCollection Date: 2020-10-01 DOI: 10.4103/jrpp.JRPP_20_49
Enos M Rampamba, Johanna C Meyer, Elvera Helberg, Brian Godman

Objective: Controlling blood pressure (BP) in hypertensive patients is a challenge, with the lack of antihypertensive medicines negatively impacting on BP control. Consequently, we assessed the availability of prescribed antihypertensives among patients with chronic hypertension attending primary health care (PHC) facilities in a rural province of South Africa and explored any association between medicines availability, the number of prescribed antihypertensive medicines and BP control.

Methods: Secondary data that included patients' demographics, BP, and data on medicines availability of the intervention group from a 3 months' operational study conducted in rural PHC facilities in South Africa were analyzed. The association between medicines availability, the number of antihypertensive medicines, and BP control was explored.

Findings: Fifty-five African patients (89.1% females) with a mean age of 61.3 years were included. Two-thirds (67.2%) received all their medicines during their monthly visits, 25.5% received some, and for 7.3%, there was no record of whether medicines were dispensed or not. Patients with controlled BP (60.0%) were more likely to have been prescribed only one antihypertensive medicine compared to patients with uncontrolled BP (20.7%) (P = 0.017; odds ratio: 5.75; 95% confidence interval: 1.46, 22.61).

Conclusion: It is concerning that one-third of patients went home without all of their antihypertensive medicines from PHC facilities in this Province of South Africa where there is evidence of use of herbal medicines and uncontrolled BP contributing to high morbidity and mortality from cardiovascular diseases. Additional studies are needed to fully explore the association between medicines availability, their use, and BP control among patients.

目的:控制高血压患者的血压是一个挑战,缺乏降压药会对血压控制产生负面影响。因此,我们评估了南非一个农村省份初级卫生保健(PHC)机构的慢性高血压患者处方抗高血压药物的可获得性,并探讨了药物可获得性、处方抗高血压药物数量和血压控制之间的关系。方法:从南非农村初级保健机构进行的为期3个月的业务研究中,分析了包括患者人口统计学、血压和干预组药物可用性数据在内的次要数据。探讨药物可及性、降压药数量与血压控制之间的关系。结果:55例非洲患者(89.1%为女性),平均年龄61.3岁。三分之二(67.2%)的人在每月就诊时获得了全部药品,25.5%的人获得了部分药品,7.3%的人没有是否配药的记录。血压控制的患者(60.0%)比血压不控制的患者(20.7%)更有可能只开过一种降压药(P = 0.017;优势比:5.75;95%置信区间:1.46,22.61)。结论:令人担忧的是,在南非的这个省,有三分之一的患者回家时没有服用所有的抗高血压药物,有证据表明使用草药和不受控制的血压导致心血管疾病的高发病率和死亡率。需要进一步的研究来充分探索药物的可获得性、使用和患者血压控制之间的关系。
{"title":"Medicines Availability among Hypertensive Patients in Primary Health Care Facilities in a Rural Province in South Africa: Findings and Implications.","authors":"Enos M Rampamba,&nbsp;Johanna C Meyer,&nbsp;Elvera Helberg,&nbsp;Brian Godman","doi":"10.4103/jrpp.JRPP_20_49","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_49","url":null,"abstract":"<p><strong>Objective: </strong>Controlling blood pressure (BP) in hypertensive patients is a challenge, with the lack of antihypertensive medicines negatively impacting on BP control. Consequently, we assessed the availability of prescribed antihypertensives among patients with chronic hypertension attending primary health care (PHC) facilities in a rural province of South Africa and explored any association between medicines availability, the number of prescribed antihypertensive medicines and BP control.</p><p><strong>Methods: </strong>Secondary data that included patients' demographics, BP, and data on medicines availability of the intervention group from a 3 months' operational study conducted in rural PHC facilities in South Africa were analyzed. The association between medicines availability, the number of antihypertensive medicines, and BP control was explored.</p><p><strong>Findings: </strong>Fifty-five African patients (89.1% females) with a mean age of 61.3 years were included. Two-thirds (67.2%) received all their medicines during their monthly visits, 25.5% received some, and for 7.3%, there was no record of whether medicines were dispensed or not. Patients with controlled BP (60.0%) were more likely to have been prescribed only one antihypertensive medicine compared to patients with uncontrolled BP (20.7%) (<i>P</i> = 0.017; odds ratio: 5.75; 95% confidence interval: 1.46, 22.61).</p><p><strong>Conclusion: </strong>It is concerning that one-third of patients went home without all of their antihypertensive medicines from PHC facilities in this Province of South Africa where there is evidence of use of herbal medicines and uncontrolled BP contributing to high morbidity and mortality from cardiovascular diseases. Additional studies are needed to fully explore the association between medicines availability, their use, and BP control among patients.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"9 4","pages":"181-185"},"PeriodicalIF":1.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/be/6c/JRPP-9-181.PMC8067899.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38919311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Journal of Research in Pharmacy Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1